rs121917881

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PP3_ModerateBS1_Supporting

The NM_005413.4(SIX3):​c.206G>A​(p.Gly69Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000218 in 1,583,932 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G69C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00016 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00022 ( 0 hom. )

Consequence

SIX3
NM_005413.4 missense

Scores

3
5
11

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 2.69

Publications

4 publications found
Variant links:
Genes affected
SIX3 (HGNC:10889): (SIX homeobox 3) This gene encodes a member of the sine oculis homeobox transcription factor family. The encoded protein plays a role in eye development. Mutations in this gene have been associated with holoprosencephaly type 2. [provided by RefSeq, Oct 2009]
SIX3-AS1 (HGNC:40532): (SIX3 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.874
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000159 (24/151266) while in subpopulation NFE AF = 0.00031 (21/67650). AF 95% confidence interval is 0.000208. There are 0 homozygotes in GnomAd4. There are 8 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SIX3NM_005413.4 linkc.206G>A p.Gly69Asp missense_variant Exon 1 of 2 ENST00000260653.5 NP_005404.1 O95343

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SIX3ENST00000260653.5 linkc.206G>A p.Gly69Asp missense_variant Exon 1 of 2 1 NM_005413.4 ENSP00000260653.3 O95343

Frequencies

GnomAD3 genomes
AF:
0.000159
AC:
24
AN:
151266
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000726
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000310
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000101
AC:
21
AN:
208576
AF XY:
0.000111
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000304
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000204
Gnomad OTH exome
AF:
0.000188
GnomAD4 exome
AF:
0.000225
AC:
322
AN:
1432666
Hom.:
0
Cov.:
32
AF XY:
0.000198
AC XY:
141
AN XY:
711852
show subpopulations
African (AFR)
AF:
0.0000303
AC:
1
AN:
32960
American (AMR)
AF:
0.0000690
AC:
3
AN:
43458
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25824
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38978
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85060
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
36272
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5578
European-Non Finnish (NFE)
AF:
0.000281
AC:
311
AN:
1105068
Other (OTH)
AF:
0.000118
AC:
7
AN:
59468
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
20
40
61
81
101
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000159
AC:
24
AN:
151266
Hom.:
0
Cov.:
31
AF XY:
0.000108
AC XY:
8
AN XY:
73810
show subpopulations
African (AFR)
AF:
0.0000726
AC:
3
AN:
41316
American (AMR)
AF:
0.00
AC:
0
AN:
15222
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3460
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5162
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10330
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
310
European-Non Finnish (NFE)
AF:
0.000310
AC:
21
AN:
67650
Other (OTH)
AF:
0.00
AC:
0
AN:
2082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000285
Hom.:
0
Bravo
AF:
0.000117
ExAC
AF:
0.0000705
AC:
8

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Holoprosencephaly 2 Uncertain:1
Aug 06, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 69 of the SIX3 protein (p.Gly69Asp). This variant is present in population databases (rs121917881, gnomAD 0.02%). This missense change has been observed in individual(s) with holoprosencephaly (HPE), although in one individual a clearly pathogenic variant was also observed suggesting the p.Gly69Asp missense was not the primary cause of disease (PMID: 17001667, 18791198). ClinVar contains an entry for this variant (Variation ID: 487087). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SIX3 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Intellectual disability Uncertain:1
Aug 28, 2019
Cambridge Genomics Laboratory, East Genomic Laboratory Hub, NHS Genomic Medicine Service
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Schizencephaly;C1834877:Holoprosencephaly 2 Uncertain:1
Sep 15, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Benign
-0.054
T
BayesDel_noAF
Uncertain
0.0
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Benign
0.35
T
Eigen
Benign
-0.30
Eigen_PC
Benign
-0.22
FATHMM_MKL
Benign
0.60
D
LIST_S2
Benign
0.50
T
M_CAP
Pathogenic
0.95
D
MetaRNN
Pathogenic
0.87
D
MetaSVM
Uncertain
-0.085
T
MutationAssessor
Benign
0.34
N
PhyloP100
2.7
PrimateAI
Pathogenic
0.91
D
PROVEAN
Benign
-0.69
N
REVEL
Uncertain
0.54
Sift
Benign
0.079
T
Sift4G
Uncertain
0.011
D
Polyphen
0.28
B
Vest4
0.69
MutPred
0.70
Loss of methylation at R71 (P = 0.0754);
MVP
0.89
MPC
1.3
ClinPred
0.090
T
GERP RS
2.5
Varity_R
0.16
gMVP
0.65
Mutation Taster
=35/65
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121917881; hg19: chr2-45169449; API